# Dev9 manuscript top-journal comparison and bounded repair iteration

*Task: FIG2-DEV9-HELDOUT27 · scope: nine development manuscripts · date: 2026-08-25 EDT*

---

## 🧭 Decision and authority boundary

This review compares the nine Dev9 manuscripts with 14 accessible, published
clinical and methodological anchors. Three of those anchors are especially
strong editorial comparators: the JAMA sepsis-phenotype study,[^jama-phenotype]
the Lancet Respiratory Medicine time-varying ventilation study,[^lrm-ventilation]
and the Scientific Data clinical time-series benchmark.[^scientific-data]
Other papers are field-specific method and reporting anchors rather than claims
that every journal in the set is a general medical top journal.

The comparison is deliberately asymmetric. Published papers define expectations
for study-population reporting, time zero, variable definitions, missingness and
censoring, modelling and sensitivity analyses, figures, and conclusion limits.
Their effect sizes are never treated as expected answers for EasyICU. Agreement
with a published result would not establish external validity, and disagreement
would not by itself invalidate the current run.

All nine runs remain `analysis_only`; publication authority is 0/9. This review
can support Writer remediation and scientific work planning. It cannot grant
clinical, causal, novelty, independent-review, or submission authority.

## 📚 Comparator set

The run-bound source pack contains 14/14 accessible full texts. Its core pairs
are:

| Dev9 task | Published comparison focus | Representative anchors |
|---|---|---|
| E1 Sepsis-3 epidemiology | denominator, definition completeness, exposure opportunity | Amsterdam UMCdb Sepsis-3;[^aumc-sepsis] UK critical-care Sepsis-3[^uk-sepsis] |
| E2 lactate and mortality | measurement process, non-linearity, multicentre context | relative hyperlactataemia and mortality[^lactate] |
| E3 KDIGO gradient | ascertainment timing, stage gradient, sensitivity definitions | ICU AKI incidence and time course[^aki] |
| M1 hepatobiliary missingness | measurement-by-indication, missing-not-normal framing | MARS early hyperbilirubinaemia study[^bilirubin] |
| M2 mortality prediction | discrimination, calibration, utility, external validation | Scientific Data benchmark;[^scientific-data] Ontario external validation[^ontario] |
| M3 sepsis subphenotypes | stability, validation, restrained phenotype naming | JAMA derivation/validation;[^jama-phenotype] multicentre validation[^jama-validation] |
| H1 ventilation survival | time-varying exposure and non-proportional hazards | Lancet Respiratory Medicine registry study[^lrm-ventilation] |
| H2 vasopressor causal question | comparator definition, positivity, timing | early norepinephrine propensity analysis;[^norepinephrine] MIMIC-IV timing study[^mimic-pressor] |
| H3 trajectory clustering | K selection, alternative algorithms, external replication | organ-dysfunction trajectory subphenotyping[^trajectory] |

For a later EasyICU platform paper, a second comparator layer is needed. Recent
published biomedical-agent systems emphasize external task benchmarks, ablation,
expert review, reference verification, and explicit failure-mode analysis—for
example Robin in Nature,[^robin] CellVoyager in Nature Methods,[^cellvoyager]
DeepEvidence in Nature Machine Intelligence,[^deepevidence] and Biomni in
Science.[^biomni] Those system-level papers are not substitutes for the
case-specific clinical anchors above.

## 📊 Reproduced 9 × 7 comparison

The exact run-bound review contains 63 decisions: 31 `meets_anchor`, 25
`actionable_gap`, 6 `fail_closed_appropriate`, and 1 `not_applicable`.

| Task | Meets | Actionable gaps | Correct fail-closed | N/A | Main unresolved issue |
|---|---:|---:|---:|---:|---|
| E1 | 3 | 4 | 0 | 0 | post-baseline opportunity, repeated stays, adjustment authority, external reproduction |
| E2 | 4 | 3 | 0 | 0 | measurement-by-indication, adjustment authority, external reproduction |
| E3 | 4 | 3 | 0 | 0 | post-baseline AKI ascertainment, repeated stays, external reproduction |
| M1 | 4 | 3 | 0 | 0 | measurement-by-indication, adjustment authority, external reproduction |
| M2 | 5 | 2 | 0 | 0 | no temporal/external validation or recalibration |
| M3 | 4 | 3 | 0 | 0 | low stability and cross-algorithm agreement, incomplete missing-data source layer |
| H1 | 4 | 3 | 0 | 0 | informative censoring/missingness sensitivity and external reproduction |
| H2 | 0 | 2 | 4 | 1 | no verified nonuse/delayed comparator; causal contrast unidentified |
| H3 | 3 | 2 | 2 | 0 | K optimum at search boundary; alternative algorithm and baseline panels absent |

The comparison therefore does not support a blanket statement that the papers
need only English polishing. Several defects are scientific-design or data
authority gaps that Writer must disclose but cannot close.

## ✍️ Deterministic Writer repair

The unmodified source replay initially returned `changes_required` for all nine
manuscripts. A new provider-free audit mode now applies only repairs that can be
derived from prose already present in the draft; source run directories remain
untouched. The replay produced:

| Task | Provider-free outcome | Remaining reader-quality owner |
|---|---|---|
| E1 | changes required | adjustment conflict, internal terms, result/discussion contradiction |
| E2 | pass | none; three overprecise display values rounded |
| E3 | changes required | abstract label and internal terms |
| M1 | changes required | one internal-term error after three structural repairs |
| M2 | changes required | unnamed metric and internal terms |
| M3 | changes required | unnamed metric and internal terms |
| H1 | changes required | internal terms; manuscript also needs rebinding to the later time-varying-Cox package |
| H2 | changes required | internal terms; scientific conclusion must remain a terminal non-solution |
| H3 | pass | abstract wrappers restored without inventing a phenotype claim |

E2 and H3 passed the provider-free replay with 0 Provider calls. The subsequent
official reporting resumes produced current quality-audit passes for E2, E3,
M1, M2, M3, H1, H2, and H3: 8/9 manuscripts. Their incremental reporting cost
was 284,944 tokens and an estimated USD 3.19588; the resumed run directories
contain 998,987 cumulative tokens and USD 12.35109 including prior Writer work.
All eight post-readiness three-role reviews still recommend `major_revision`.

E1 remains `changes_required`. Its Methods say age and sex, whereas the executed
primary-model evidence and design columns say age and `charlson_max`; five section
owners also require migration. The source run has already consumed 92,811 tokens,
the transport requires a minimum 132,096-token reservation, and the routine E1
iteration ceiling is 100,000 tokens. Another E1 resume was therefore not started.
This is a safety and evidence-consistency stop, not an unfinished copy-edit.

## 🧑‍⚕️ Simulated reviewer 1: clinical design and interpretation

**Recommendation: major revision before journal selection.** The cohort and
clinical-definition reporting is generally stronger than the first writing
replay suggested. The largest problems are temporal rather than rhetorical:
E1/E3 have post-baseline ascertainment opportunities; E2/M1 retain
measurement-by-indication; H2 lacks an identifiable comparator. These issues
must be handled by prespecified landmark/descriptive decisions or retained as
limitations/fail-closed results. H2 should not be rewritten as a causal paper
until comparator status and positivity are verified.

## 📐 Simulated reviewer 2: statistics and reproducibility

**Recommendation: major revision, with task-specific stopping rules.** M2 has a
credible internal reporting suite—AUROC, AUPRC, Brier score, calibration,
decision-curve analysis, and grouped repeats—but those are not a substitute for
temporal or external validation. M3 and H3 correctly expose instability rather
than naming clusters, but they need a second robustness axis and external
replication before phenotype claims. H1's newer time-varying Cox remediation
improves the handling of severe proportional-hazards violation, but the old
Writer overlay must not be presented as if it contains that later analysis.
Across studies, patient-level identity and repeated-stay dependence remain an
explicit data limitation wherever identity is unavailable.

## 📰 Simulated reviewer 3: editorial fit, novelty, and presentation

**Recommendation: do not submit the nine-paper portfolio in its current form.**
The manuscripts are now substantive rather than empty scaffolds, but most are
2,200–3,100 words and still read like development reports in places. A journal
editor will need one sharply stated contribution per paper, direct positioning
against the closest anchor, and a Results/Discussion sequence that distinguishes
executed evidence, limitations, and next validation. Negative results can be
publishable only when framed as informative boundary findings with complete
methods and diagnostics; they must not be inflated into positive biological or
causal claims.

For the eventual EasyICU system paper, the strongest publishable contribution is
not “the agent reproduced published effect sizes.” It is the typed,
evidence-bound workflow that can both complete analyses and refuse unidentified
ones. To compete with recent biomedical-agent papers, that claim will require a
frozen external benchmark, human/expert evaluation, ablation of key authority
components, failure taxonomy, cost/latency reporting, and reproducibility on an
exact released system.

## 🔧 Repair queue

The next iteration is owner-scoped:

1. **No-model repairs:** retain E2 and H3 repaired candidates; keep the new
   provider-free replay as the first triage stage. In this iteration, the E2
   pipeline resume added 134,635 tokens although the current deterministic
   replay can close its display-precision error without a Provider call.
2. **E1 evidence adjudication:** confirm the authorized adjustment set from the
   executed primary-model contract, then migrate only its five failing sections
   under a newly approved budget. Do not silently choose age/sex or
   age/Charlson in prose.
3. **Evidence rebinding:** regenerate H1 reporting from the later
   `de6403a` time-varying-Cox package before any prose polishing.
4. **Scientific-owner work:** do not ask Writer to close external validation,
   repeated-stay identity, comparator positivity, measurement-by-indication,
   or unstable clustering.
5. **Acceptance:** current manuscript quality audit passes for every regenerated
   draft; numeric, literature, and critique audits remain clean; exact source
   digests are recorded; and an independent clinical/method review remains an
   explicit gate.

This three-reviewer exercise is a structured internal simulation, not independent
peer review. Its purpose is to prioritize repair and prevent prose improvements
from being mistaken for stronger evidence.

[^aumc-sepsis]: [Application of the Sepsis-3 criteria to Amsterdam UMCdb](https://pubmed.ncbi.nlm.nih.gov/38905261/).
[^uk-sepsis]: [Descriptors of Sepsis Using the Sepsis-3 Criteria](https://pubmed.ncbi.nlm.nih.gov/34259454/).
[^lactate]: [Relative hyperlactataemia and hospital mortality](https://pubmed.ncbi.nlm.nih.gov/20181242/).
[^aki]: [Acute kidney injury in intensive care patients](https://pubmed.ncbi.nlm.nih.gov/35674748/).
[^bilirubin]: [Early hyperbilirubinaemia in critically ill patients](https://pubmed.ncbi.nlm.nih.gov/34238904/).
[^scientific-data]: [Multitask learning and benchmarking with clinical time series data](https://pubmed.ncbi.nlm.nih.gov/31209213/).
[^ontario]: [External validation of an ICU mortality prognostic model](https://pubmed.ncbi.nlm.nih.gov/32383124/).
[^jama-phenotype]: [Derivation and validation of clinical phenotypes for sepsis](https://pubmed.ncbi.nlm.nih.gov/31104070/).
[^jama-validation]: [Multicenter validation of clinical sepsis phenotypes](https://pubmed.ncbi.nlm.nih.gov/42223936/).
[^lrm-ventilation]: [Time-varying mechanical-ventilation intensity and mortality](https://pubmed.ncbi.nlm.nih.gov/32735841/).
[^norepinephrine]: [Very early norepinephrine in septic shock](https://pubmed.ncbi.nlm.nih.gov/32059682/).
[^mimic-pressor]: [Norepinephrine timing and fluids in MIMIC-IV](https://pubmed.ncbi.nlm.nih.gov/37073334/).
[^trajectory]: [Sepsis subphenotyping based on organ-dysfunction trajectory](https://pubmed.ncbi.nlm.nih.gov/35786445/).
[^robin]: [A multi-agent system for automating scientific discovery](https://www.nature.com/articles/s41586-026-10652-y).
[^cellvoyager]: [CellVoyager](https://www.nature.com/articles/s41592-026-03029-6).
[^deepevidence]: [DeepEvidence](https://www.nature.com/articles/s42256-026-01266-0).
[^biomni]: [Autonomous biomedical research with an artificial intelligence agent](https://pubmed.ncbi.nlm.nih.gov/42424436/).
